CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 342 enrolled
Drug / intervention
metformin +3 moredrug
Likely dose
metformin 0.5gfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02491333
NCT02491333Phase 3Completed
CompareCT.gov

The Effect of Acupuncture on Insulin Sensitivity of Women With Polycystic Ovary Syndrome and Insulin Resistance: a Randomized Controlled Trial

The First Affiliated Hospital of Guangzhou Medical University·interventional·Posted Jul 8, 2015·Updated Mar 21, 2022

In Brief

A Phase 3 clinical trial evaluating true acupuncture, sham acupuncture, and 2 other interventions for Polycystic Ovary Syndrome and Insulin Resistance. Completed, enrolled 342 participants across 1 site.

Detailed Summary

The objectives of this randomized controlled trial are to compare insulin sensitivity following true acupuncture + placebo metformin (Group 1) vs sham acupuncture + placebo metformin (Group 2) vs sham acupuncture + metformin (Group 3) in women with PCOS and IR.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPolycystic Ovary Syndrome, Insulin Resistance
CountriesChina
CollaboratorsThe University of Hong Kong, Karolinska Institutet

Timeline

Phase 3CompletedFinished
20162017201820192020202120222023202420252026
First PostedJul 8, 2015
Enrollment StartAug 1, 2015
Primary CompletionOct 1, 2018
TodayJul 2, 2026
Enrollment to primary: 3.2 yearsPosted 11.0 years ago

Interventions

true acupunctureother

True acupuncture treatment will be given three times per week. Each treatment session lasts for 30 minutes and can be separated by an interval of 1-3 days, with a maximum of 48 treatment sessions during 4 month.

sham acupunctureother

Sham acupuncture treatment will be given three times per week. Each treatment session lasts for 30 minutes and can be separated by an interval of 1-3 days, with a maximum of 48 treatment sessions during 4 month.

metformindrug

Metformin will be given at 0.5g/times, 3 times one day and for 4 month.

Placebo metformindrug

Placebo metformin will be given at 0.5g/times, 3 times one day and for 4 month.